You are here

Generic Percocet Approved by FDA

CORONA, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that it has received final approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Oxycodone and Acetaminophen (APAP) tablets in 7.5mg/325mg and 10mg/325mg strengths. Oxycodone/APAP is the generic equivalent to Endo Pharmaceuticals' Percocet® tablets and is indicated for the relief of moderate to moderately severe pain. For the 12-months ending June 2003, Percocet® 7.5mg/325mg and 10mg/325mg had sales of approximately $142 million.

The Company expects a full launch by late 2003 and timing is dependent on obtaining quota from the Drug Enforcement Administration, adequate supply of active ingredient, and build-up of launch quantities.

Source: Watson Pharmaceuticals, Inc.

Recent Headlines

Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs